The immunogenicity and safety of respiratory syncytial virus vaccines in development: A systematic review.
Jing ShanPhilip N BrittonCatherine L KingRobert BooyPublished in: Influenza and other respiratory viruses (2021)
LID ∆M2-2, MEDI M2-2, RSVcps2 and LID/∆M2-2 /1030s (live-attenuated) were considered the most promising vaccine candidates in infant and children. In the elderly, a nanoparticle F vaccine candidate and Ad26.RSV.preF were considered as two potential effective vaccines. A promising maternal vaccine candidate is still lacking.